Phenmetrazine (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Phenmetrazine" in English language version.

refsWebsite

Global rank English rank

6nih.gov

4^th place

5doi.org

2^nd place

2web.archive.org

1^st place

2archive.org

6^th place

1in.gov.br

3,151^st place

5,932^nd place

1espacenet.com

800^th place

676^th place

1google.com

163^rd place

185^th place

1semanticscholar.org

11^th place

8^th place

1patents.google.com

1,182^nd place

725^th place

1druglibrary.org

low place

archive.org

Miles B (1998). Paul McCartney: Many Years from Now. H. Holt. pp. 66–67. ISBN 0-8050-5248-8.
Davies H (1968). The Beatles: The Authorized Biography. New York, McGraw-Hill Book Co. p. 78. ISBN 0-07-015457-0.

doi.org

Thomä O, Wick H (1954). "Über einige Tetrahydro-1,4-oxazine mit sympathicomimetischen Eigenschaften". Arch. Exp. Pathol. Pharmakol. 222 (6): 540. doi:10.1007/BF00246905. S2CID 25143525.
Hampson J, Loraine JA, Strong JA (June 1960). "Phenmetrazine and dexamphetamine in the management of obesity". Lancet. 1 (7137): 1265–1267. doi:10.1016/S0140-6736(60)92250-9. PMID 14399386.
Rothman RB, Baumann MH (2006). "Therapeutic potential of monoamine transporter substrates". Current Topics in Medicinal Chemistry. 6 (17): 1845–1859. doi:10.2174/156802606778249766. PMID 17017961. Archived from the original on 26 March 2017. Retrieved 5 May 2020.{{cite journal}}: CS1 maint: unfit URL (link)
Engelhardt A (1961). "Studies of the Mechanism of the Anti-Appetite Action of Phenmetrazine". Biochem. Pharmacol. 8 (1): 100. doi:10.1016/0006-2952(61)90520-2.
Choi H, Baeck S, Jang M, Lee S, Choi H, Chung H (February 2012). "Simultaneous analysis of psychotropic phenylalkylamines in oral fluid by GC-MS with automated SPE and its application to legal cases". Forensic Science International. 215 (1–3): 81–87. doi:10.1016/j.forsciint.2011.02.011. PMID 21377815.

druglibrary.org

Brecher EM. "The Swedish Experience". Retrieved 31 October 2009.

espacenet.com

worldwide.espacenet.com

GB 773780, Boehringer A, Boehringer E, "Improvements in or relating to the preparation of substituted morpholines"

google.com

US patent 2835669, Thomä O, "Process for the Production of Substituted Morpholines", issued 20 May 1958, assigned to C. H. Boehringer Sohn

in.gov.br

Anvisa (31 March 2023). "RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial" [Collegiate Board Resolution No. 784 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese). Diário Oficial da União (published 4 April 2023). Archived from the original on 3 August 2023. Retrieved 16 August 2023.

nih.gov

pubmed.ncbi.nlm.nih.gov

Martel A (January 1957). "Preludin (phenmetrazine) in the treatment of obesity". Canadian Medical Association Journal. 76 (2): 117–120. PMC 1823494. PMID 13383418.
"Phenmetrazine hydrochloride". Journal of the American Medical Association. 163 (5): 357. February 1957. PMID 13385162.
Hampson J, Loraine JA, Strong JA (June 1960). "Phenmetrazine and dexamphetamine in the management of obesity". Lancet. 1 (7137): 1265–1267. doi:10.1016/S0140-6736(60)92250-9. PMID 14399386.
Rothman RB, Baumann MH (2006). "Therapeutic potential of monoamine transporter substrates". Current Topics in Medicinal Chemistry. 6 (17): 1845–1859. doi:10.2174/156802606778249766. PMID 17017961. Archived from the original on 26 March 2017. Retrieved 5 May 2020.{{cite journal}}: CS1 maint: unfit URL (link)
Choi H, Baeck S, Jang M, Lee S, Choi H, Chung H (February 2012). "Simultaneous analysis of psychotropic phenylalkylamines in oral fluid by GC-MS with automated SPE and its application to legal cases". Forensic Science International. 215 (1–3): 81–87. doi:10.1016/j.forsciint.2011.02.011. PMID 21377815.

ncbi.nlm.nih.gov

Martel A (January 1957). "Preludin (phenmetrazine) in the treatment of obesity". Canadian Medical Association Journal. 76 (2): 117–120. PMC 1823494. PMID 13383418.

patents.google.com

WO 2011146850, Blough BE, Rothman R, Landavazo A, Page KM, Decker AM, "Phenylmorpholines and analogues thereof", assigned to Research Triangle Institute, pages 51,54–55

semanticscholar.org

api.semanticscholar.org

Thomä O, Wick H (1954). "Über einige Tetrahydro-1,4-oxazine mit sympathicomimetischen Eigenschaften". Arch. Exp. Pathol. Pharmakol. 222 (6): 540. doi:10.1007/BF00246905. S2CID 25143525.

web.archive.org

Anvisa (31 March 2023). "RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial" [Collegiate Board Resolution No. 784 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese). Diário Oficial da União (published 4 April 2023). Archived from the original on 3 August 2023. Retrieved 16 August 2023.
Rothman RB, Baumann MH (2006). "Therapeutic potential of monoamine transporter substrates". Current Topics in Medicinal Chemistry. 6 (17): 1845–1859. doi:10.2174/156802606778249766. PMID 17017961. Archived from the original on 26 March 2017. Retrieved 5 May 2020.{{cite journal}}: CS1 maint: unfit URL (link)